Susan has a life time commitment to the development of good public policy, sustainable development advocacy and constructive political engagement. She is Director of Public Policy Engagement at Gavi, the Vaccine Alliance, which consists of WHO, UNICEF, the Bill and Melinda Gates Foundation, World Bank and other partners.
Previous to this role, she was Director of Global and Regional Policy and Head of the Policy and External Affairs Cluster for WWF International - a 100 country, €600m organisation – representing and negotiating for them in hundreds of global and regional political and policy dialogues, achieving significant text outcomes and commitments for all areas of sustainable development.
Over 14 years of multilateral negotiation work, she has developed a deep understanding of geopolitical dynamics, considerable knowledge of the behaviours and motivations of decision makers and the process of decision making. She has built strong relationships with country governments, global institutions and civil society organisations at executive level and led global network teams to significant recognition of their objectives in major international processes and forums including the UN 2030 Agenda for Sustainable Development (the Sustainable Development Goals), UN resolutions, the Convention on Biological Diversity (2008, 2010, 2014) the UNFCCC preparatory meetings and Copenhagen COP of 2009, the UN Environment Assembly, Rio +20 (2012), the World Summit of 2005, the World Health Assembly, 12 UN General Assemblies and many others.
Prior achievements include key roles in the substantial expansion and reform of Federal environmental law in Australia (the EPBC Act negotiations), achieving a significant package new and changed spending of energy measures and new environment funding through the GST negotiations, running a conservation organisation covering an extensive area of northern Australia including range lands, complex river systems and the Great Barrier Reef, news and opinion pieces for most of Australia’s major newspapers and operating a successful media consultancy.
Dr Zijian Feng, is the Deputy Director-General of Chinese Center for Disease Control and Prevention (China CDC), who is in charge of the Health Emergency Center, Department of Communicable Diseases, Center of National Immunization Program, Office of Epidemiology, Institute of Communicable Diseases, and the Institute of Parasitic Diseases.
Dr Feng is a seasoned expert with over 30 years’ experiences in public health emergency response, communicable disease control and children immunization program. He is the member of the National Emergency Response Advisory Committee and the member of Disease Control and Prevention Advisory Committee of Chinese National Health Commission. He is also the Chairman Elected for Public Health Committee of China Medical Association. Dr Feng is also the Editor for several scientific journals, such as the Chinese Journal for Vaccines and Immunization, Journal of Chinese Preventive Medicine and Journal of Modern Preventive Medicine, et al.
Prior to current position, he had been the Director of Office for Disease Control and Emergency Response; Director of General Administration Office; and Associate Director, Center of National Immunization Program in China CDC since 2002. Before joining China CDC, he was the Deputy Director-General of Henan Provincial CDC where he worked since 1986. During the Ebola Outbreak in West Africa, he was deployed to Liberia as WHO designated senior advisor for The United Nations Mission for Ebola Emergency Response from Dec 2014 to Feb 2015.
Dr. Feng obtained his Bachelor degree of Medicine from Henan Medical University and Master degree in Public Health from the Chinese Union Medical University. He has published over 80 scientific articles on international journals and Chinese journals, including The Lancet, the New England Journal of Medicine, PLoS Medicine, BMJ, Clinical Infectious Diseases, Journal of Infectious Diseases, Emerging Infectious Diseases, and Vaccine.
Richard J. Hatchett, MD, is Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership of public, private, philanthropic and civil organizations that will finance and co-ordinate the development of vaccines against high priority public health threats and vaccine platform technologies to respond rapidly to emerging infectious diseases with pandemic or epidemic potential.
Prior to joining CEPI, Richard most recently served as acting Director of the U.S. Biomedical Advanced Research and Development Authority (BARDA), after serving for five years as BARDA’s Chief Medical Officer and Deputy Director.
During his time at BARDA, he oversaw programs to develop medical countermeasures against chemical, biological, radiological and nuclear threats, pandemic influenza, and emerging infectious diseases. He also helped lead the development of vaccines, therapeutics, and diagnostics for a number of emerging viruses, including the H3N2v and H7N9 influenza viruses, MERS, Ebola, and Zika.
Richard served on the White House Homeland Security Council under President George W. Bush and was a member of the White House National Security Staff under President Barack Obama. He is a recipient of the HHS Secretary’s Award for Distinguished Service and a five-time recipient of the NIH Director’s Merit Award.
Richard is a graduate of Vanderbilt University and the Vanderbilt University Medical School, he completed a residency in internal medicine at the New York Hospital – Cornell Medical Centre and a fellowship in medical oncology at Duke University Medical Centre.
Dr Takeshi Kasai began his term as WHO Regional Director for the Western Pacific on 1 February 2019, following his nomination by the WHO Regional Committee for the Western Pacific and his appointment by the WHO Executive Board.
The public health career of Dr Kasai began nearly 30 years ago when he was assigned to a remote post on the northeast coast of Japan, providing health-care services for the elderly. His early experiences there impressed upon him value of building strong health systems from the ground up. In the mid-1990s, Dr Kasai attended the London School of Hygiene & Tropical Medicine, where he studied in the Department of Global Health and Development and received a master’s degree in public health.
Dr Kasai has worked for WHO for more than 15 years, and at the time of his nomination was Director of Programme Management, the No. 2 position at the WHO Regional Office for the Western Pacific in Manila, Philippines. As a Technical Officer and later as the Director of the Division of Health Security at the Regional Office, he was instrumental in developing and implementing the Asia Pacific Strategy for Emerging Diseases and Public Health Emergencies, which guides Member States in preparing for and responding to public health emergencies.
Dr Kasai also served as the WHO Representative in Viet Nam from 2012 to 2014, and in 2014 received the For the People’s Health Medal from the Government, the top honor bestowed upon those who have made significant contributions to public health.
Dr Kasai is from Japan. He is married and has three daughters.
Dr. Nkengasong Director of the Africa Centers for Disease Control and Prevention. Prior to his current position, he served as the acting deputy principal director (acting) of the Center for Global Health, United States Centers for Disease Control and Prevention (U.S. CDC), and Chief of the International Laboratory Branch, Division of Global HIV and TB., U.S CDC. He received a Masters in Tropical Biomedical Science at the Institute of Tropical Medicine in Antwerp, Belgium, and another Masters Degree in Medical and Pharmaceutical Sciences at the University of Brussels School of Medicine and a Doctorate in Medical Sciences (Virology) from the University of Brussels, Belgium. Between 1993-95 he was Chief of the Virology and the WHO Collaborating Center on HIV diagnostics, at the Department of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium. He joined the U.S., CDC in 1995 as Chief of the Virology Laboratory, U.S., CDC Abidjan, Ivory Coast. He has received numerous awards for his work including, but not limited to, the U.S. Secretary of Health and Human Services Award for excellence in Public Health Protection Research, the Sheppard Award, the U.S. Director’s Recognitions Award and, most recently, the William Watson Medal of Excellence, the highest recognition awarded by CDC. Awarded for outstanding contributions and leadership in advancing global laboratory services and programs to support the President’s Emergency Plan for AIDS Relief. He is also recipient of the Knight of Honour Medal by the Government of Cote d’Ivoire, was knighted in 2017 as the Officer of Loin by the President of Senegal, H.E. Macky Sall, and Knighted in November 2018 by the government of Cameroon for his significant contributions to public health. He is an adjunct professor at the Emory School of Public Health, Emory university, Atlanta, GA. He serves on several international advisory boards including the Coalition for Epidemic Preparedness Initiative – CEPI, the International AIDS Vaccine Initiative (IAVI) among others. He has authored over 200 peer-review articles in international journals and published several book chapters.
Mrs Olubunmi Eyitayo Ojo is the Deputy Director of Disease Surveillance and Epidemiology at the Nigeria Centre for Disease Control. She is also the Project Coordinator of Nigeria’s World Bank Regional Disease Surveillance Strengthening and Enhancement project (REDISSE) where she manages the $90 million credit for One Health strengthening.
Olubunmi has worked as the IHR National focal point responsible for Nigeria for the last eight years, playing a significant role in communication with the World Health Organisation.
In her primary role as Director of Surveillance, she manages the surveillance arm of the national public health institute, with focus on reporting and analysis of data of Nigeria’s epidemic prone diseases- Lassa fever, cholera, measles, yellow fever, cerebrospinal meningitis and monkeypox.
Peter Sands has been the Executive Director of The Global Fund for AIDS, Tuberculosis and Malaria since March 2018.
Since June 2015 Peter has been a Research Fellow at Harvard University, dividing his time between the Mossavar-Rahmani Center for Business and Government at Harvard Kennedy School and the Harvard Global Health Institute.
Peter was Group CEO of Standard Chartered PLC from November 2006 to June 2015, having joined the Board of Standard Chartered as Group CFO in May 2002.
Prior to joining Standard Chartered, Peter was a Senior Partner at McKinsey & Co.
Peter has served on various boards and commissions, including as Lead Non-Executive Director of the UK Department of Health, Director of the World Economic Forum/Davos, Member of the International Advisory Board of the Monetary Authority of Singapore, Member of the China People’s Association for Friendship with Foreign People’s Global CEO Council, and Co-Chair of the UK-India CEO Forum.
Peter graduated from Oxford University with a First Class degree in Politics, Philosophy and Economics. He also received a Master in Public Administration from Harvard University, where he was a Harkness Fellow. Peter, who grew up in Singapore and Malaysia, is married to author and bookshop owner, Betsy Tobin and has four children.
Dr Poonam Khetrapal Singh, an Indian national, became the first woman to assume the office of WHO Regional Director for South-East Asia on 1 February 2014. In September 2018 Member States unanimously nominated Dr Khetrapal Singh for a second five-year term as Regional Director. The 144th Session of the WHO Executive Board formally appointed her to the position on 26 January 2019.
Dr Khetrapal Singh’s second term will be defined by a simple though powerful maxim: ‘Sustain. Accelerate. Innovate’. Each of the above pillars complements Dr Khetrapal Singh’s original ‘1 by 4’ plan and the seven (later to become eight) Flagship Priorities that anchored Region-wide progress since 2014.
Prior to Dr Khetrapal Singh’s appointment as Regional Director of the WHO South-East Asia Region, for over two decades she was a civil servant in India as a member of the Indian Administrative Services. This included roles as both Joint-Secretary and Secretary of Health in the State of Punjab, which has a population of 27 million and a health budget of US$ 350 million.
In 1987 she moved to the Health, Population and Nutrition Department of The World Bank. In 1998 she joined WHO headquarters as Executive Director, Sustainable Development and Healthy Environments Cluster, and became a member of the Director-General’s Cabinet.
Dr Khetrapal Singh then served as WHO Deputy Regional Director for the South-East Asia Region from 2000 to 2013. In February 2013 she joined the Ministry of Health and Family Welfare of the Government of India as Advisor for International Health, where her principal task was to strengthen global health outcomes and provide guidance to the Ministry to take forward the international health agenda.
Further Invited Speakers will be announced shortly, please stay tuned for further updates. Accompanying the Invited Speakers there will be 300+ Oral and Poster abstracts presented.
|Online registration & accommodation:|
|26 July 2018|
|Call for Abstracts:|
|Notification to authors:|
|31 January 2019|
|Travel bursary announcements:|
|31 January 2019|
|1 March 2019|
|Early bird deadline:|
|18 March 2019|
Conference participation will be capped between 700 to 1,000 places. Delegates will be required to register in advance, and a minimum of 200 places will be reserved for participants from low-income countries.